Cancel
Known information
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, a biopharmaceutical company, develops treatments for neurodegenerative diseases and conducts global clinical trials. The company plans to withdraw RELYVRIO/ALBRIOZA from the market and reduce its workforce by approximately 70% to focus on key programs.
Report inaccurate information